DK0973546T3 - Stabiliserede formuleringer med human papillomavirus - Google Patents
Stabiliserede formuleringer med human papillomavirusInfo
- Publication number
- DK0973546T3 DK0973546T3 DK98915319T DK98915319T DK0973546T3 DK 0973546 T3 DK0973546 T3 DK 0973546T3 DK 98915319 T DK98915319 T DK 98915319T DK 98915319 T DK98915319 T DK 98915319T DK 0973546 T3 DK0973546 T3 DK 0973546T3
- Authority
- DK
- Denmark
- Prior art keywords
- human papillomavirus
- stabilized formulations
- formulations
- hpv
- polysorbate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4280897P | 1997-04-08 | 1997-04-08 | |
GBGB9709351.2A GB9709351D0 (en) | 1997-05-07 | 1997-05-07 | Stabilized human papillomavirus formulations |
PCT/US1998/006825 WO1998044944A2 (fr) | 1997-04-08 | 1998-04-07 | Formulations stabilisees du virus du papillome humain |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0973546T3 true DK0973546T3 (da) | 2004-06-28 |
Family
ID=26311501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98915319T DK0973546T3 (da) | 1997-04-08 | 1998-04-07 | Stabiliserede formuleringer med human papillomavirus |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0973546B1 (fr) |
JP (1) | JP4598201B2 (fr) |
KR (1) | KR20010006169A (fr) |
CN (1) | CN1259051A (fr) |
AT (1) | ATE261734T1 (fr) |
AU (1) | AU739829B2 (fr) |
CA (1) | CA2286294A1 (fr) |
DE (1) | DE69822452T2 (fr) |
DK (1) | DK0973546T3 (fr) |
EE (1) | EE9900612A (fr) |
ES (1) | ES2216280T3 (fr) |
IL (1) | IL132201A0 (fr) |
NO (1) | NO994879L (fr) |
NZ (1) | NZ500028A (fr) |
PL (1) | PL336715A1 (fr) |
PT (1) | PT973546E (fr) |
SK (1) | SK138199A3 (fr) |
WO (1) | WO1998044944A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
EP1150712B1 (fr) * | 1999-02-05 | 2008-11-05 | Merck & Co., Inc. | Formulations vaccinales contre le virus du papillome humain |
US6245568B1 (en) * | 1999-03-26 | 2001-06-12 | Merck & Co., Inc. | Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
DE10137102A1 (de) | 2001-07-30 | 2003-02-27 | Deutsches Krebsforsch | Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung |
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
TW200806315A (en) * | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
EP2601969B1 (fr) | 2006-09-29 | 2016-03-30 | Takeda Vaccines, Inc. | Formulations de vaccin contre un norovirus |
JP2010539192A (ja) | 2007-09-18 | 2010-12-16 | リゴサイト ファーマスーティカルズ,インコーポレイテッド | ノロウイルスに対して防御免疫応答を付与する方法 |
WO2009092113A2 (fr) * | 2008-01-19 | 2009-07-23 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methodes et compositions d'administration de vaccins dans un epithelium rompu |
CN103260642B (zh) * | 2010-12-14 | 2018-03-16 | 葛兰素史密丝克莱恩生物有限公司 | 分枝杆菌抗原组合物 |
CN102085354A (zh) * | 2010-12-30 | 2011-06-08 | 重庆大学 | 一种治疗人乳头瘤病毒16型引发的肿瘤的多肽药物 |
PL3299030T3 (pl) | 2011-07-11 | 2022-12-05 | Takeda Vaccines, Inc. | Pozajelitowe preparaty szczepionek przeciw norowirusowi |
CN105039358B (zh) * | 2013-12-03 | 2020-02-28 | 北京康乐卫士生物技术股份有限公司 | 58型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
AR101840A1 (es) * | 2014-09-11 | 2017-01-18 | Cadila Healthcare Ltd | Antígenos del virus del papiloma humano superiores con propiedades inmunológicas superiores, y vacuna que los contiene |
CN106399329B (zh) * | 2015-08-12 | 2021-06-11 | 北京康乐卫士生物技术股份有限公司 | 33型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN106701797B (zh) * | 2015-08-12 | 2021-06-15 | 北京康乐卫士生物技术股份有限公司 | 31型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN108201623A (zh) * | 2016-12-19 | 2018-06-26 | 无锡鑫连鑫生物医药科技有限公司 | 人乳头瘤病毒重组四价疫苗、其制备方法及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2949031A1 (de) * | 1978-12-15 | 1980-07-17 | Sandoz Ag | Vakzine |
EP0732936B1 (fr) * | 1993-12-09 | 2000-03-29 | Heinrich Exner | Adjuvant pour antigenes, son procede de production et son utilisation |
AUPM566794A0 (en) * | 1994-05-17 | 1994-06-09 | University Of Queensland, The | Process and product |
AR004464A1 (es) * | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
IL117459A (en) * | 1995-03-22 | 2005-11-20 | Merck & Co Inc | Dna encoding human papillomavirus type 18 |
IL117591A0 (en) * | 1995-03-30 | 1996-07-23 | Merck & Co Inc | Synthetic DNA encoding human papillomavirus type 11 L1 protein |
-
1998
- 1998-04-07 PL PL98336715A patent/PL336715A1/xx unknown
- 1998-04-07 DK DK98915319T patent/DK0973546T3/da active
- 1998-04-07 CN CN98805728A patent/CN1259051A/zh active Pending
- 1998-04-07 WO PCT/US1998/006825 patent/WO1998044944A2/fr active IP Right Grant
- 1998-04-07 CA CA002286294A patent/CA2286294A1/fr not_active Abandoned
- 1998-04-07 AT AT98915319T patent/ATE261734T1/de not_active IP Right Cessation
- 1998-04-07 KR KR1019997009248A patent/KR20010006169A/ko not_active Application Discontinuation
- 1998-04-07 JP JP54301498A patent/JP4598201B2/ja not_active Expired - Fee Related
- 1998-04-07 EE EEP199900612A patent/EE9900612A/xx unknown
- 1998-04-07 IL IL13220198A patent/IL132201A0/xx unknown
- 1998-04-07 AU AU69533/98A patent/AU739829B2/en not_active Ceased
- 1998-04-07 ES ES98915319T patent/ES2216280T3/es not_active Expired - Lifetime
- 1998-04-07 NZ NZ500028A patent/NZ500028A/en unknown
- 1998-04-07 PT PT98915319T patent/PT973546E/pt unknown
- 1998-04-07 DE DE69822452T patent/DE69822452T2/de not_active Expired - Lifetime
- 1998-04-07 EP EP98915319A patent/EP0973546B1/fr not_active Expired - Lifetime
- 1998-04-07 SK SK1381-99A patent/SK138199A3/sk unknown
-
1999
- 1999-10-07 NO NO994879A patent/NO994879L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO994879D0 (no) | 1999-10-07 |
DE69822452D1 (de) | 2004-04-22 |
CA2286294A1 (fr) | 1998-10-15 |
WO1998044944A2 (fr) | 1998-10-15 |
AU6953398A (en) | 1998-10-30 |
ES2216280T3 (es) | 2004-10-16 |
NZ500028A (en) | 2001-08-31 |
DE69822452T2 (de) | 2006-04-20 |
EP0973546B1 (fr) | 2004-03-17 |
JP4598201B2 (ja) | 2010-12-15 |
IL132201A0 (en) | 2001-03-19 |
PL336715A1 (en) | 2000-07-03 |
PT973546E (pt) | 2004-06-30 |
NO994879L (no) | 1999-12-07 |
WO1998044944A3 (fr) | 1998-12-30 |
CN1259051A (zh) | 2000-07-05 |
SK138199A3 (en) | 2000-06-12 |
KR20010006169A (ko) | 2001-01-26 |
ATE261734T1 (de) | 2004-04-15 |
AU739829B2 (en) | 2001-10-18 |
EE9900612A (et) | 2000-08-15 |
EP0973546A2 (fr) | 2000-01-26 |
JP2001519814A (ja) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0973546T3 (da) | Stabiliserede formuleringer med human papillomavirus | |
DE69531314D1 (de) | Verwendung von metallionen chelatoren zur stabilisierung von interferon-enthaltenden pharmazeutischen zubereitungen | |
HK1014156A1 (en) | Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant | |
IS4067A (is) | PEG-Interferonafleiður, aðferð til framleiðslu þeirra, og notkunar sem lyfja | |
SE9503143D0 (sv) | New preparation | |
DE60137122D1 (de) | Winkelähnlichkeitsoperator mit verallgemeinertem lensing | |
DE59310197D1 (de) | Lagerstabile wässrige pharmazeutische zubereitungen von g-csf | |
NO20004721L (no) | Bruseformuleringer | |
DE69636953D1 (de) | Lyophilisierte hgf-zubereitungen | |
PL346764A1 (en) | New oral formulation for 5-ht4 | |
CA2060560A1 (fr) | Methode pour assurer un apport suffisant en glutathione intracellulaire dans les tissus | |
MXPA03005221A (es) | Composicion farmaceutica de dronedarona para administracion parenteral. | |
MXPA05009135A (es) | Formulaciones liquidas de las proteinas de union del factor necrosis del tumor. | |
BR9809708A (pt) | Composições farmacêuticas de peptìdeos tendo solubilidade baixa em meio fisiológico | |
UY27373A1 (es) | Formulaciones de interferón beta-humano | |
PT1091740E (pt) | Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona | |
ATE341339T1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
SE8402199L (sv) | Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist | |
ATE301453T1 (de) | Injizierbare arzneiformulierungen von partricin derivaten | |
EA199900915A1 (ru) | Стабилизированные композиции вируса папилломы человека | |
DE60135845D1 (de) | Pralmorelin-haltige nasentropfen-präparate | |
ES2073063T3 (es) | Formulaciones galenicas acuosas de eritropoyetina y su uso. | |
RU2003124254A (ru) | Косметическое средство для ухода за кожей лица и шеи |